US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 56.290
  • -0.090-0.16%
Close Jan 17 16:00 ET
  • 56.510
  • +0.220+0.39%
Post 20:01 ET
114.17BMarket Cap-15.72P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bristol-Myers Squibb Q4 2024 Estimates Date

Currency：USDFeb 6, 2025

Estimate YoY
Revenue
11.53B
+0.43%
EPS
0.90
+3.39%
Analyst Rating
Hold

Jan 15, 2025

Bristol-Myers Squibb Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20252025/Q1-- / 11.438B--
Feb 6, 20252024/Q4-- / 11.526B--
Oct 31, 20242024/Q311.892B / 11.246B--
Jul 26, 20242024/Q212.201B / 11.522B--
Apr 25, 20242024/Q111.865B / 11.451B--
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20252025/Q1-- / 11.438B--
Feb 6, 20252024/Q4-- / 11.526B--
Oct 31, 20242024/Q311.892B / 11.246B--
Jul 26, 20242024/Q212.201B / 11.522B--
Apr 25, 20242024/Q111.865B / 11.451B--

Unlock Free Earnings Estimates

Bristol-Myers Squibb Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Oct 31, 2024 11:46 ET

  • 8-K: Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

    Oct 31, 2024 07:55 ET

  • 10-Q: Q2 2024 Earnings Report

    Jul 26, 2024 12:08 ET

  • 8-K: Bristol Myers Squibb Reports Second Quarter Financial Results for 2024

    Jul 26, 2024 07:48 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 15, 2025

    Hold

    • Buy

      27.78%

    • Hold

      61.11%

    • Sell

      11.11%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Cancer Research
    Cancer Research
    Intraday-0.95%